ABHD6

abhydrolase domain containing 6, acylglycerol lipase, the group of Abhydrolase domain containing

Basic information

Region (hg38): 3:58237531-58295693

Links

ENSG00000163686NCBI:57406OMIM:616966HGNC:21398Uniprot:Q9BV23AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ABHD6 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABHD6 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
14
clinvar
14
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 14 0 0

Variants in ABHD6

This is a list of pathogenic ClinVar variants found in the ABHD6 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-58256608-A-T not specified Uncertain significance (Aug 12, 2021)2390096
3-58256621-C-T not specified Uncertain significance (Jan 03, 2024)3131116
3-58256689-A-C not specified Uncertain significance (Nov 30, 2022)2329718
3-58267221-G-A not specified Uncertain significance (Mar 30, 2024)2369328
3-58267295-A-C not specified Uncertain significance (Mar 31, 2024)3323259
3-58269330-A-G not specified Uncertain significance (Oct 27, 2021)2257746
3-58269367-A-G not specified Uncertain significance (Oct 05, 2023)3131115
3-58270986-A-G not specified Uncertain significance (Jun 17, 2024)3323517
3-58274711-G-C not specified Uncertain significance (Sep 29, 2022)2314484
3-58274720-G-A not specified Uncertain significance (Feb 05, 2024)3131122
3-58274820-C-T Benign (Dec 13, 2017)708984
3-58285110-G-A not specified Uncertain significance (Mar 20, 2024)3323343
3-58285126-C-A not specified Uncertain significance (Dec 17, 2023)3131124
3-58285134-G-A not specified Uncertain significance (Dec 02, 2022)2332092
3-58285415-A-G not specified Uncertain significance (May 30, 2024)3323430
3-58293598-G-A not specified Uncertain significance (Sep 14, 2023)2623954
3-58293643-G-T not specified Uncertain significance (Dec 16, 2022)2336009
3-58293742-G-C not specified Uncertain significance (May 30, 2023)2552585
3-58293743-A-G not specified Uncertain significance (Oct 04, 2022)2374532

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ABHD6protein_codingprotein_codingENST00000478253 858188
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00002230.9151257280201257480.0000795
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7631671970.8470.00001092216
Missense in Polyphen4960.2070.81385636
Synonymous0.4237478.80.9390.00000459657
Loss of Function1.621017.20.5808.17e-7200

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00008680.0000868
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.00004620.0000462
European (Non-Finnish)0.0001150.000114
Middle Eastern0.0001630.000163
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Lipase that preferentially hydrolysis medium-chain saturated monoacylglycerols including 2-arachidonoylglycerol (PubMed:22969151). Through 2-arachidonoylglycerol degradation may regulate endocannabinoid signaling pathways. May also have a lysophosphatidyl lipase activity with a preference for lysophosphatidylglycerol among other lysophospholipids (By similarity). {ECO:0000250|UniProtKB:Q8R2Y0, ECO:0000269|PubMed:22969151}.;
Pathway
Retrograde endocannabinoid signaling - Homo sapiens (human);Signaling by GPCR;Signal Transduction;Effects of PIP2 hydrolysis;Platelet activation, signaling and aggregation;Arachidonate production from DAG;Hemostasis;triacylglycerol degradation;G alpha (q) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.419

Intolerance Scores

loftool
0.448
rvis_EVS
-0.49
rvis_percentile_EVS
22.09

Haploinsufficiency Scores

pHI
0.0485
hipred
N
hipred_score
0.394
ghis
0.623

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.179

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Abhd6
Phenotype

Gene ontology

Biological process
phospholipid catabolic process;negative regulation of cell migration;acylglycerol catabolic process;positive regulation of lipid biosynthetic process;long-term synaptic depression;negative regulation of cold-induced thermogenesis;regulation of endocannabinoid signaling pathway
Cellular component
mitochondrion;plasma membrane;integral component of membrane;AMPA glutamate receptor complex;glutamatergic synapse;GABA-ergic synapse;integral component of postsynaptic membrane
Molecular function
phospholipase activity;acylglycerol lipase activity